Circulating free plasma tumor DNA in patients with advanced gastric cancer receiving systemic chemotherapy

BACKGROUND: Advanced gastric cancers are usually associated with incurable conditions for which systemic treatments are indicated. Recent studies suggest that circulating cell-free plasma DNA of tumour origin (tDNA) is a promising non-invasive biomarker that can be used to predict the prognosis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Normando, Sávia Raquel Costa, Delgado, Pamela de Oliveira, Rodrigues, Ana Katherine Soares Barbosa, David Filho, Waldec Jorge, Fonseca, Fernando Luiz Affonso, Cruz, Felipe José Silva Melo, del Giglio, Auro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258437/
https://www.ncbi.nlm.nih.gov/pubmed/30498396
http://dx.doi.org/10.1186/s12907-018-0079-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258437/
https://www.ncbi.nlm.nih.gov/pubmed/30498396
http://dx.doi.org/10.1186/s12907-018-0079-y

Ejemplares similares